Bdescu SV, Ttaru C, Kobylinska L, Georgescu EL, Zahiu DM, Zgrean AM, Zgrean L (2016) The association between diabetes mellitus and depression
Krishnappa M, Patil K, Parmar K et al (2020) Effect of saroglitazar 2 mg and 4 mg on glycemic control, lipid profile and cardiovascular disease risk in patients with type 2 diabetes mellitus: a 56-week, randomized, double blind, phase 3 study (PRESS XII study)
suggests that improvements in methylation may explain the benefits of B12 in ASD, 27 whilst the results from Bertoglio et al
Jordan Miller later presented the teams findings at UT San Antonios Los Datos conference, where she took home first prize
Melanoma &mdash
#GLP1 medicines now address weight loss and other health conditions through innovative formulations and expanded indications, highlighting key questions about their efficacy and safety